Clinical Trial Update: Evaluate the Safety and Efficacy of a 5-HT4 Agonist in Chronic Constipation (ACCORD Trial) [Phase 2]

View source ↗

Summary

Phase 2 ACCORD trial evaluating the safety and efficacy of a 5-HT4 receptor agonist for chronic constipation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation

Drugs mentioned

• 5-HT4 receptor agonist (ACCORD trial)

Snippet

Sponsor: Alfasigma S.p.A. | Conditions: Chronic Constipation | Phase 2 | Status: COMPLETED